000 | 01858 a2200517 4500 | ||
---|---|---|---|
005 | 20250516003901.0 | ||
264 | 0 | _c20110304 | |
008 | 201103s 0 0 eng d | ||
022 | _a1530-0293 | ||
024 | 7 |
_a10.1097/CCM.0b013e3181fa3dfe _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNeto-Neves, Evandro M | |
245 | 0 | 0 |
_aMetalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism. _h[electronic resource] |
260 |
_bCritical care medicine _cFeb 2011 |
||
300 |
_a349-56 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCardiac Output |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aDoxycycline _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemodynamics _xphysiology |
650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xmetabolism |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aPulmonary Embolism _xdrug therapy |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aTroponin I _xblood |
650 | 0 | 4 |
_aVentricular Dysfunction, Right _xpathology |
700 | 1 | _aDias-Junior, Carlos A | |
700 | 1 | _aRizzi, Elen | |
700 | 1 | _aCastro, Michele M | |
700 | 1 | _aSonego, Fabiane | |
700 | 1 | _aGerlach, Raquel F | |
700 | 1 | _aTanus-Santos, Jose E | |
773 | 0 |
_tCritical care medicine _gvol. 39 _gno. 2 _gp. 349-56 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/CCM.0b013e3181fa3dfe _zAvailable from publisher's website |
999 |
_c20218155 _d20218155 |